Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Retinal Disorder Treatment Market by Type (Gels, Capsules & Tablets, Eye Drops, Ointments), By Application (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Retinal Disorder Treatment Market by Type (Gels, Capsules & Tablets, Eye Drops, Ointments), By Application (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 168272 3300 Medical Devices & Consumables 377 235 Pages 5 (48)
                                          

Market Overview:


The global retinal disorder treatment market is expected to grow at a CAGR of 6.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of retinal disorders, rising awareness about available treatments, and growing demand for advanced therapies. By type, the global retinal disorder treatment market is segmented into gels, capsules & tablets, eye drops, and ointments. The gels segment is expected to account for the largest share of the global retinal disorder treatment market in 2018 owing to its high efficacy and ease of use. By application, the hospital pharmacy segment is expected to account for the largest share of the global retinal disorder treatment market in 2018 owing to increased spending on healthcare by governments and private players across regions.


Global Retinal Disorder Treatment Industry Outlook


Product Definition:


A retinal disorder is a problem with the retina, the thin layer of tissue at the back of your eye that senses light and helps you see. Retinal disorders can cause vision problems and even blindness. Treatment for a retinal disorder may include prescription eyeglasses, medications, or surgery. It's important to seek treatment for a retinal disorder as soon as possible to preserve your vision.


Gels:


Gels are a form of ocular drug delivery system that is used to deliver drugs to the retina. They are also known as colloidal systems and can be categorized on the basis of their physical state (liquid, semi-solid or solid), route of administration ( topical, oral or intravenous) and type (ionic, nonionic).


Capsules & Tablets:


Capsules and tablets are the two most commonly used dosage forms in the treatment of retinal disorders. They can be easily administered to patients by eye care professionals or self-administered at home with the help of a syringe, dropper, or oral solids. The most common types of capsules used for treating retinal disorders are soft gelatin capsules and hard gelatin capsules.


Application Insights:


Based on application, the market is segmented into hospital pharmacy, online pharmacy, and retail pharmacy. The hospital Pharmacy segment dominated the market in 2017 owing to a high prevalence of retinal disorders coupled with rising awareness among patients regarding treatment options. In addition, hospitals form an essential part of society and are considered as one of its most important institutions that provide critical healthcare services to its citizens. As such a large number of patients visits hospitals for various reasons including accidents and illness therefore demand for medicines increase at same time supply does too which results in increasing demand for Retinal Disorder Treatment Market by Hospital Pharmacy.


Regional Analysis:


North America dominated the global market in 2017. The presence of key players, favorable reimbursement policies, and rising prevalence of retinal disorders are some factors responsible for its growth. In addition, increasing adoption of new technologies and growing healthcare awareness among people are contributing to the regional market’s growth.


Asia Pacific is expected to grow at a lucrative rate during the forecast period owing to high unmet medical needs coupled with rapidly improving healthcare infrastructure and economic development in emerging countries such as China & India. Furthermore, public & private partnerships between governments & NGOs; increased R&D investments; improved regulatory framework governing medical devices manufacturing; free trade agreements between countries etc.


Growth Factors:


  • Increasing prevalence of retinal disorders
  • Growing awareness about available treatments for retinal disorders
  • Rising demand for better and advanced treatment options for retinal disorders
  • Technological advancements in the field of ophthalmology that are helping to improve diagnosis and treatment of retinal disorders 5. increasing healthcare expenditure by governments and private players to support research and development activities for Retinal Disorder Treatment market

Scope Of The Report

Report Attributes

Report Details

Report Title

Retinal Disorder Treatment Market Research Report

By Type

Gels, Capsules & Tablets, Eye Drops, Ointments

By Application

Hospital Pharmacy, Online Pharmacy, Retail Pharmacy

By Companies

Santen Pharmaceutical, REGENERON, Graybug Vision, Takeda Pharmaceuticals, Bayer, Roche-Genentech, Acucela, Pfizer

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

235

Number of Tables & Figures

165

Customization Available

Yes, the report can be customized as per your need.


Global Retinal Disorder Treatment Market Report Segments:

The global Retinal Disorder Treatment market is segmented on the basis of:

Types

Gels, Capsules & Tablets, Eye Drops, Ointments

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Hospital Pharmacy, Online Pharmacy, Retail Pharmacy

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Santen Pharmaceutical
  2. REGENERON
  3. Graybug Vision
  4. Takeda Pharmaceuticals
  5. Bayer
  6. Roche-Genentech
  7. Acucela
  8. Pfizer

Global Retinal Disorder Treatment Market Overview


Highlights of The Retinal Disorder Treatment Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Gels
    2. Capsules & Tablets
    3. Eye Drops
    4. Ointments
  1. By Application:

    1. Hospital Pharmacy
    2. Online Pharmacy
    3. Retail Pharmacy
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Retinal Disorder Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Retinal Disorder Treatment Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


There is no one-size-fits-all answer to this question, as the best treatment for a particular retinal disorder will vary depending on the individual's symptoms and medical history. However, some common treatments for retinal disorders include laser therapy, surgery, and medication.

Some of the key players operating in the retinal disorder treatment market are Santen Pharmaceutical, REGENERON, Graybug Vision, Takeda Pharmaceuticals, Bayer, Roche-Genentech, Acucela, Pfizer.

The retinal disorder treatment market is expected to grow at a compound annual growth rate of 6.5%.

                                            
1. Executive Summary

2. Assumptions and Acronyms Used

3. Research Methodology

4. Retinal Disorder Treatment Market Overview
   4.1. Introduction
      4.1.1. Market Taxonomy
      4.1.2. Market Definition
   4.2. Macro-Economic Factors
      4.2.1. Industry Outlook
   4.3. Retinal Disorder Treatment Market Dynamics
      4.3.1. Market Drivers
      4.3.2. Market Restraints
      4.3.3. Opportunity
      4.3.4. Market Trends
   4.4. Retinal Disorder Treatment Market - Supply Chain
   4.5. Global Retinal Disorder Treatment Market Forecast
      4.5.1. Retinal Disorder Treatment Market Size (US$ Mn) and Y-o-Y Growth
      4.5.2. Retinal Disorder Treatment Market Size (000’ Units) and Y-o-Y Growth
      4.5.3. Retinal Disorder Treatment Market Absolute $ Opportunity

5. Global Retinal Disorder Treatment Market Analysis and Forecast by Type
   5.1. Market Trends
   5.2. Introduction
      5.2.1. Basis Point Share (BPS) Analysis by Type
      5.2.2. Y-o-Y Growth Projections by Type
   5.3. Retinal Disorder Treatment Market Size and Volume Forecast by Type
      5.3.1. Gels
      5.3.2. Capsules & Tablets
      5.3.3. Eye Drops
      5.3.4. Ointments
   5.4. Absolute $ Opportunity Assessment by Type
   5.5. Market Attractiveness/Growth Potential Analysis by Type

6. Global Retinal Disorder Treatment Market Analysis and Forecast by Application
   6.1. Market Trends
   6.2. Introduction
      6.2.1. Basis Point Share (BPS) Analysis by Application
      6.2.2. Y-o-Y Growth Projections by Application
   6.3. Retinal Disorder Treatment Market Size and Volume Forecast by Application
      6.3.1. Hospital Pharmacy
      6.3.2. Online Pharmacy
      6.3.3. Retail Pharmacy
   6.4. Absolute $ Opportunity Assessment by Application
   6.5. Market Attractiveness/Growth Potential Analysis by Application

7. Global Retinal Disorder Treatment Market Analysis and Forecast by Sales Channel
   7.1. Market Trends
   7.2. Introduction
      7.2.1. Basis Point Share (BPS) Analysis by Sales Channel 
      7.2.2. Y-o-Y Growth Projections by Sales Channel
   7.3. Retinal Disorder Treatment Market Size and Volume Forecast by Sales Channel 
      7.3.1. Manufacturer/Distributor/Service Provider
      7.3.2. Aftermarket
   7.4. Absolute $ Opportunity Assessment by Sales Channel
   7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel

8. Global Retinal Disorder Treatment Market Analysis and Forecast by Region
   8.1. Market Trends
   8.2. Introduction
      8.2.1. Basis Point Share (BPS) Analysis by Region
      8.2.2. Y-o-Y Growth Projections by Region
   8.3. Retinal Disorder Treatment Market Size and Volume Forecast by Region
      8.3.1. North America
      8.3.2. Latin America
      8.3.3. Europe
      8.3.4. Asia Pacific
      8.3.5. Middle East and Africa (MEA)
   8.4. Absolute $ Opportunity Assessment by Region
   8.5. Market Attractiveness/Growth Potential Analysis by Region
   8.6. Global Retinal Disorder Treatment Demand Share Forecast, 2019-2026

9. North America Retinal Disorder Treatment Market Analysis and Forecast
   9.1. Introduction
      9.1.1. Basis Point Share (BPS) Analysis by Country
      9.1.2. Y-o-Y Growth Projections by Country
   9.2. North America Retinal Disorder Treatment Market Size and Volume Forecast by Country
      9.2.1. U.S.
      9.2.2. Canada
   9.3. Absolute $ Opportunity Assessment by Country
   9.4. North America Retinal Disorder Treatment Market Size and Volume Forecast by Application
      9.4.1. Hospital Pharmacy
      9.4.2. Online Pharmacy
      9.4.3. Retail Pharmacy
   9.5. Basis Point Share (BPS) Analysis by Application
   9.6. Y-o-Y Growth Projections by Application
   9.7. North America Retinal Disorder Treatment Market Size and Volume Forecast by Type
      9.7.1. Gels
      9.7.2. Capsules & Tablets
      9.7.3. Eye Drops
      9.7.4. Ointments
   9.8. Basis Point Share (BPS) Analysis by Type
   9.9. Y-o-Y Growth Projections by Type
   9.10. Market Attractiveness/Growth Potential Analysis
      9.10.1. By Country
      9.10.2. By Product Type
      9.10.3. By Application
      9.10.4. By Sales Channel
   9.11. North America Retinal Disorder Treatment Demand Share Forecast, 2019-2026

10. Latin America Retinal Disorder Treatment Market Analysis and Forecast
   10.1. Introduction
      10.1.1. Basis Point Share (BPS) Analysis by Country
      10.1.2. Y-o-Y Growth Projections by Country
      10.1.3. Latin America Average Pricing Analysis
   10.2. Latin America Retinal Disorder Treatment Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
   10.4. Latin America Retinal Disorder Treatment Market Size and Volume Forecast by Application
      10.4.1. Hospital Pharmacy
      10.4.2. Online Pharmacy
      10.4.3. Retail Pharmacy
   10.5. Basis Point Share (BPS) Analysis by Application
   10.6. Y-o-Y Growth Projections by Application
   10.7. Latin America Retinal Disorder Treatment Market Size and Volume Forecast by Type
      10.7.1. Gels
      10.7.2. Capsules & Tablets
      10.7.3. Eye Drops
      10.7.4. Ointments
   10.8. Basis Point Share (BPS) Analysis by Type
   10.9. Y-o-Y Growth Projections by Type
   10.10. Market Attractiveness/Growth Potential Analysis
      10.10.1. By Country
      10.10.2. By Product Type
      10.10.3. By Application
      10.10.4. By Sales Channel
   10.11. Latin America Retinal Disorder Treatment Demand Share Forecast, 2019-2026

11. Europe Retinal Disorder Treatment Market Analysis and Forecast
   11.1. Introduction
      11.1.1. Basis Point Share (BPS) Analysis by Country
      11.1.2. Y-o-Y Growth Projections by Country
      11.1.3. Europe Average Pricing Analysis
   11.2. Europe Retinal Disorder Treatment Market Size and Volume Forecast by Country
      11.2.1. Germany
      11.2.2. France
      11.2.3. Italy
      11.2.4. U.K.
      11.2.5. Spain
      11.2.6. Russia
      11.2.7. Rest of Europe
   11.3. Absolute $ Opportunity Assessment by Country
   11.4. Europe Retinal Disorder Treatment Market Size and Volume Forecast by Application
      11.4.1. Hospital Pharmacy
      11.4.2. Online Pharmacy
      11.4.3. Retail Pharmacy
   11.5. Basis Point Share (BPS) Analysis by Application
   11.6. Y-o-Y Growth Projections by Application
   11.7. Europe Retinal Disorder Treatment Market Size and Volume Forecast by Type
      11.7.1. Gels
      11.7.2. Capsules & Tablets
      11.7.3. Eye Drops
      11.7.4. Ointments
  11.8. Basis Point Share (BPS) Analysis by Type
   11.9. Y-o-Y Growth Projections by Type
   11.10. Market Attractiveness/Growth Potential Analysis
      11.10.1. By Country
      11.10.2. By Product Type
      11.10.3. By Application
      11.10.4. By Sales Channel
   11.11. Europe Retinal Disorder Treatment Demand Share, 2019-2026

12. Asia Pacific Retinal Disorder Treatment Market Analysis and Forecast
   12.1. Introduction
      12.1.1. Basis Point Share (BPS) Analysis by Country
      12.1.2. Y-o-Y Growth Projections by Country
      12.1.3. Asia Pacific Average Pricing Analysis
   12.2. Asia Pacific Retinal Disorder Treatment Market Size and Volume Forecast by Country
      12.2.1. China
      12.2.2. Japan
      12.2.3. South Korea
      12.2.4. India
      12.2.5. Australia
      12.2.6. Rest of Asia Pacific (APAC)
   12.3. Absolute $ Opportunity Assessment by Country
   12.4. Asia Pacific Retinal Disorder Treatment Market Size and Volume Forecast by Application
      12.4.1. Hospital Pharmacy
      12.4.2. Online Pharmacy
      12.4.3. Retail Pharmacy
   12.5. Basis Point Share (BPS) Analysis by Application
   12.6. Y-o-Y Growth Projections by Application
   12.7. Asia Pacific Retinal Disorder Treatment Market Size and Volume Forecast by Type
      12.7.1. Gels
      12.7.2. Capsules & Tablets
      12.7.3. Eye Drops
      12.7.4. Ointments
   12.8. Basis Point Share (BPS) Analysis by Type
   12.9. Y-o-Y Growth Projections by Type
   12.10. Market Attractiveness/Growth Potential Analysis
      12.10.1. By Country
      12.10.2. By Product Type
      12.10.3. By Application
      12.10.4. By Sales Channel
   12.11. Asia Pacific Retinal Disorder Treatment Demand Share, 2019-2026

13. Middle East & Africa Retinal Disorder Treatment Market Analysis and Forecast
   13.1. Introduction
      13.1.1. Basis Point Share (BPS) Analysis by Country
      13.1.2. Y-o-Y Growth Projections by Country
      13.1.3. Asia Pacific Average Pricing Analysis
   13.2. Middle East & Africa Retinal Disorder Treatment Market Size and Volume Forecast by Country
      13.2.1. Saudi Arabia
      13.2.2. South Africa
      13.2.3. UAE
      13.2.4. Rest of Middle East & Africa (MEA)
   13.3. Absolute $ Opportunity Assessment by Country
   13.4. Middle East & Africa Retinal Disorder Treatment Market Size and Volume Forecast by Application
      13.4.1. Hospital Pharmacy
      13.4.2. Online Pharmacy
      13.4.3. Retail Pharmacy
   13.5. Basis Point Share (BPS) Analysis by Application
   13.6. Y-o-Y Growth Projections by Application
   13.7. Middle East & Africa Retinal Disorder Treatment Market Size and Volume Forecast by Type
      13.7.1. Gels
      13.7.2. Capsules & Tablets
      13.7.3. Eye Drops
      13.7.4. Ointments
   13.8. Basis Point Share (BPS) Analysis by Type
   13.9. Y-o-Y Growth Projections by Type
   13.10. Market Attractiveness/Growth Potential Analysis
      13.10.1. By Country
      13.10.2. By Product Type
      13.10.3. By Application
      13.10.4. By Sales Channel
   13.11. Middle East & Africa Retinal Disorder Treatment Demand Share, 2019-2026

14. Competition Landscape
   14.1. Global Retinal Disorder Treatment Market: Market Share Analysis
   14.2. Retinal Disorder Treatment Distributors and Customers
   14.3. Retinal Disorder Treatment Market: Competitive Dashboard
   14.4. Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.4.1. Santen Pharmaceutical
         14.4.1.1. Overview
         14.4.1.2. Financials
         14.4.1.3. Developments
         14.4.1.4. Strategic Outlook
      14.4.2. REGENERON
         14.4.2.1. Overview
         14.4.2.2. Financials
         14.4.2.3. Developments
         14.4.2.4. Strategic Outlook
      14.4.3. Graybug Vision
         14.4.3.1. Overview
         14.4.3.2. Financials
         14.4.3.3. Developments
         14.4.3.4. Strategic Outlook
      14.4.4. Takeda Pharmaceuticals
         14.4.4.1. Overview
         14.4.4.2. Financials
         14.4.4.3. Developments
         14.4.4.4. Strategic Outlook
      14.4.5. Bayer
         14.4.5.1. Overview
         14.4.5.2. Financials
         14.4.5.3. Developments
         14.4.5.4. Strategic Outlook
      14.4.6. Roche-Genentech
         14.4.6.1. Overview
         14.4.6.2. Financials
         14.4.6.3. Developments
         14.4.6.4. Strategic Outlook
      14.4.7. Acucela
         14.4.7.1. Overview
         14.4.7.2. Financials
         14.4.7.3. Developments
         14.4.7.4. Strategic Outlook
      14.4.8. Pfizer
         14.4.8.1. Overview
         14.4.8.2. Financials
         14.4.8.3. Developments
         14.4.8.4. Strategic Outlook
      14.4.9. COMPANY9
         14.4.9.1. Overview
         14.4.9.2. Financials
         14.4.9.3. Developments
         14.4.9.4. Strategic Outlook
      14.4.10. COMPANY 10
         14.4.10.1. Overview
         14.4.10.2. Financials
         14.4.10.3. Developments
         14.4.10.4. Strategic Outlook
      14.4.11. COMPANY 11
         14.4.11.1. Overview
         14.4.11.2. Financials
         14.4.11.3. Developments
         14.4.11.4. Strategic Outlook
      14.4.12. COMPANY 12
         14.4.12.1. Overview
         14.4.12.2. Financials
         14.4.12.3. Developments
         14.4.12.4. Strategic Outlook
      14.4.13. COMPANY 13
         14.4.13.1. Overview
         14.4.13.2. Financials
         14.4.13.3. Developments
         14.4.13.4. Strategic Outlook
      14.4.14. COMPANY 14
         14.4.14.1. Overview
         14.4.14.2. Financials
         14.4.14.3. Developments
         14.4.14.4. Strategic Outlook
      14.4.15. COMPANY 15
         14.4.15.1. Overview
         14.4.15.2. Financials
         14.4.15.3. Developments
         14.4.15.4. Strategic Outlook
      14.4.16. COMPANY 16
         14.4.16.1. Overview
         14.4.16.2. Financials
         14.4.16.3. Developments
         14.4.16.4. Strategic Outlook
      14.4.17. COMPANY 17
         14.4.17.1. Overview
         14.4.17.2. Financials
         14.4.17.3. Developments
         14.4.17.4. Strategic Outlook
      14.4.18. COMPANY 18
         14.4.18.1. Overview
         14.4.18.2. Financials
         14.4.18.3. Developments
         14.4.18.4. Strategic Outlook
      14.4.19. COMPANY 19
         14.4.19.1. Overview
         14.4.19.2. Financials
         14.4.19.3. Developments
         14.4.19.4. Strategic Outlook
      14.4.20. COMPANY 20
         14.4.20.1. Overview
         14.4.20.2. Financials
         14.4.20.3. Developments
         14.4.20.4. Strategic Outlook

Our Trusted Clients

Contact Us